GFM
LKFT

GF Fund Management’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

GF Fund Management’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.5K Sell
317
-1
-0.3% -$28 ﹤0.01% 540
2026
Q1 		$9.54K Buy
318
+36
+13% +$1.19K ﹤0.01% 558
2025
Q4 		$9.22K Sell
282
-23
-8% -$743 ﹤0.01% 582
2025
Q3 		$10.6K Sell
305
-52
-15% -$1.66K ﹤0.01% 550
2025
Q2 		$9.99K Hold
357
– – ﹤0.01% 571
2025
Q1 		$8.97K Buy
357
+64
+22% +$1.62K ﹤0.01% 581
2024
Q4 		$8.06K Buy
+293
New +$8.17K ﹤0.01% 573

Other funds holding LKFT

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return
DO
denkapparat Operations Berlin, Germany $306M AUM 40.46% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

GF Fund Management's LKFT Position: Q2 2026 in Review

GF Fund Management reduced its Lakefront Biotherapeutics American Depositary Shares (LKFT) stake by 0.31% in Q2 2026, selling an estimated $28 and leaving 317 shares worth $9.5K. The position accounts for ﹤0.01% of the portfolio, ranked #540.

GF Fund Management first reported a position in LKFT in Q4 2024 and has held it in 7 quarters since. The position peaked at $10.6K in Q3 2025. 24 funds tracked by Wall St. Rank hold LKFT as of Q2 2026.

  • GF Fund Management held 317 shares of Lakefront Biotherapeutics American Depositary Shares worth $9.5K as of Q2 2026.
  • GF Fund Management sold 1 Lakefront Biotherapeutics American Depositary Shares share in Q2 2026, an estimated $28.
  • Lakefront Biotherapeutics American Depositary Shares made up ﹤0.01% of GF Fund Management's portfolio in Q2 2026, its #540 holding.
  • GF Fund Management first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q4 2024 and has held it in 7 quarters since.
  • GF Fund Management's Lakefront Biotherapeutics American Depositary Shares position peaked at $10.6K in Q3 2025.
  • 24 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q2 2026.

Based on GF Fund Management's 13F filing for Q2 2026, filed 7 Aug 2026.